Deutschpharmazie Increases the Number of Pain Relief Medications Available to Meet Rising Demands

Deutschpharmazie is now offering a larger selection of painkillers than every before

Online PR News – 06-January-2011 – – Deutschpharmazie is now offering a larger selection of painkillers than every before

January 5, 2011 - Berlin, Germany - Due to a heavy increase in sales over the last year for pain relief medications, Deutschpharmazie has decided to increase their selection and add new, popular medications for pain relief including Generic Celebrex.

Over the last few years, the popularity of NSAIDs - non-steroidal anti-inflammatory drugs - have increased due to their ability to decrease pain, inflammation, and fever, especially in individuals suffering from a form of arthritis, as well as to injuries relating to sports players. NSAIDs decrease the amount of prostaglandins produced, the chemical known for causing inflammation and pain. Because production is decreased, so is pain.

In explaining the increase in popularity in pain relief medications, product manager Paul Sommer had this to say, "In the current economic climate, many individuals are being forced to take on second or even third jobs. These additional jobs are often manual labor. One wrong move, and individuals can be in a lot of pain. However, because they need the money, they cannot afford to sit back. Analgesics, such as Voltaren, assist individuals because it reduces pain effectively and enables them to get back to work pain-free."

Generic Celebrex is an FDA approved oral analgesic medication.

Deutschpharmazie has made is possible for individual to buy Celebrex online without the need of a prescription. For any questions or concerns about taking these for pain relief, Deutschpharmazie has medical professionals on-site all day, every day, to assist individuals in determining which analgesic is right for them and what dose they should take. All conversations are kept private and confidential, to increase feelings of security on the part of the customer.